Virtual Workshop A – Keeping Canada in the Clinical Development Pipeline: Strengthening Evidence Generation and Market Access

Mar 2, 2027 9:00 am – 12:00 pm

Canada faces growing competition for global clinical trial investment, with implications for pharmaceutical innovation, research capacity and patient access to emerging therapies. Attracting and retaining clinical trial investment requires a competitive research environment and the ability to generate evidence relevant to Canadian regulatory, HTA and payer needs.

This workshop will explore how Canada can strengthen its position as a clinical research destination and better connect clinical development with future market access.

  • Identifying barriers to attracting and retaining global clinical trial investment
  • Exploring opportunities to strengthen Canada’s clinical research environment
  • Aligning evidence-generation strategies with Canadian regulatory, HTA and payer requirements
  • Examining how locally relevant evidence can inform future reimbursement and patient access